EGFR(表皮生长因子受体)
EGFR (epidermal growth factor receptor) is the cell-surface receptor of its specific ligands, including epidermal growth factor and TGFα (transforming growth factor α) and is a receptor tyrosine kinase.
Products for EGFR
- Cat.No. 产品名称 Information
- GC15600 Erlotinib Hydrochloride An EGFR tyrosine kinase inhibitor
- GC16737 Gefitinib (ZD1839) 吉非替尼(ZD1839)是一种强效的表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI),IC50为0.033 µM,能选择性抑制表皮生长因子刺激的肿瘤细胞生长,IC50为0.054 µM,并能阻断表皮生长因子刺激的表皮生长因子受体(EGFR)在肿瘤细胞中的自身磷酸化。.
- GC13608 Lapatinib A dual inhibitor of EGFR and ErbB2
- GC16593 Lapatinib Ditosylate Lapatinib Ditosylate (GW572016 ditosylate monohydrate) 是有效的 ErbB-2 和 EGFR 酪氨酸激酶结构域抑制剂,对纯化的 EGFR 和 ErbB-2 的 IC50 值分别为 10.2 和 9.8 nM。
- GC16869 Ixabepilone A broad-spectrum anticancer agent
- GC16244 Icotinib Hydrochloride An EGFR inhibitor
- GC14295 Gefitinib hydrochloride An EGFR inhibitor
- GC10627 Erlotinib An EGFR tyrosine kinase inhibitor
- GC14695 CO-1686 (AVL-301) A selective inhibitor of mutant EGFR
- GC12087 Canertinib dihydrochloride A pan-ErbB tyrosine kinase inhibitor
- GC13873 BMS-690514 BMS-690514 是一种有效的、具有口服活性的 EGFR 和 VEGFR 抑制剂;对 EGFR、HER 2 和 HER 4 的 IC50 分别为 5、20 和 60 nM。
- GC10606 BMS-599626 Hydrochloride BMS-599626 Hydrochloride (AC480 Hydrochloride) 是一种选择性的口服生物可利用的 HER1 和 HER2 抑制剂,IC50 分别为 20 和 30 nM。 BMS-599626 Hydrochloride 对 HER4 (IC50=190 nM) 的效力降低约 8 倍,对 VEGFR2、c-Kit、Lck、MEK 的效力超过 100 倍。 BMS-599626 Hydrochloride 抑制肿瘤细胞增殖,并有可能增加肿瘤对放疗的反应。
- GC10087 BIBX 1382 An EGFR inhibitor
- GC10707 Afatinib dimaleate An inhibitor of EGFR and ErbB2
- GC15589 WHI-P154 A JAK3 inhibitor
- GC16008 CUDC-101 A multi-target inhibitor of HDACs, EGFR, and HER2
- GC15983 PD 153035 hydrochloride A highly potent EGFR inhibitor
- GC12837 Compound 56 A potent EGFR inhibitor
- GN10327 Chrysophanol An anthraquinone with diverse biological activities
- GN10336 Daphnetin A coumarin derivative with diverse biological activities